- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Ann Arbor Stage IV Hodgkin Lymphoma
Total 7708 results
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingNon-hodgkin Lymphoma,B CellChina
-
BioInvent International ABRecruitingIndolent B-Cell Non-Hodgkin LymphomaSpain, United States, Brazil, Sweden, Germany, Poland
-
Hoffmann-La RocheCompletedB-cell Non-Hodgkin LymphomaUnited States, Spain, Korea, Republic of, France, Austria, Poland
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedT Cell Non-Hodgkin LymphomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Immunoblastic Large Cell Lymphoma and other conditionsUnited States
-
Tessa TherapeuticsActive, not recruitingHodgkin Lymphoma, Adult | Hodgkin Disease Recurrent | Hodgkin Disease Refractory | Hodgkin Disease, PediatricUnited States
-
AbbVie (prior sponsor, Abbott)CompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Peripheral T-cell Lymphoma | Lymphoid Malignancies | Chronic Lymphoid LeukemiaUnited States, Canada
-
Bristol-Myers SquibbCompletedCancer - Solid Tumors and B-Cell Non-Hodgkin's LymphomaUnited States, France, Spain, Germany
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | B-cell Non-Hodgkin's LymphomaUnited States
-
University of WashingtonGenentech, Inc.RecruitingMarginal Zone Lymphoma | Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Indolent B-Cell Non-Hodgkin Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal Zone...United States
-
The Lymphoma Academic Research OrganisationRoche Pharma AGTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin LymphomaFrance
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Myelofibrosis | Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Refractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Lymphoid Malignancies | Relapsed Non-Hodgkin Lymphoma and other conditionsUnited States
-
Baylor College of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); The Methodist... and other collaboratorsRecruitingLymphoma | Non-Hodgkin's Lymphoma | Hodgkin's Disease | Lymphoproliferative DiseaseUnited States
-
Sohag UniversityNot yet recruiting
-
Centre Hospitalier Universitaire DijonRecruitingNon-hodgkin's LymphomaFrance
-
Xynomic Pharmaceuticals, Inc.Cancer Institute and Hospital, Chinese Academy of Medical SciencesActive, not recruitingNon Hodgkin LymphomaChina
-
MorphoSys AGCompletedNon-Hodgkin LymphomaUnited States, Belgium, Germany, Hungary, Italy, Poland, Spain
-
Gilead SciencesTerminated
-
Assiut UniversityCompleted
-
Novartis PharmaceuticalsCompletedNeoplasms | Non-Hodgkin LymphomaUnited States, Netherlands
-
Institut Paoli-CalmettesCompletedNon-Hodgkin LymphomaFrance
-
University of BelgradeUnknownNon-hodgkin LymphomaSerbia
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.The First Affiliated Hospital of Zhengzhou UniversityUnknown
-
Nordic NanovectorWithdrawnNon-Hodgkin LymphomaGermany
-
Samsung Medical CenterMillennium Pharmaceuticals, Inc.CompletedNon-Hodgkin LymphomaKorea, Republic of
-
Beijing Immunochina Medical Science & Technology...Peking University Cancer Hospital & InstituteUnknownNon Hodgkin LymphomaChina
-
Centre Leon BerardAmgenTerminated
-
Radboud University Medical CenterUnknown
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Genzyme, a Sanofi CompanyCompleted
-
Asociacion Espanola de Hematologia y HemoterapiaCompleted
-
Instituto Nacional de Cancerologia de MexicoUnknownNon-Hodgkin LymphomaMexico
-
Chiron CorporationTerminatedNon-Hodgkin LymphomaUnited States
-
Baylor College of MedicineThe Methodist Hospital Research InstituteRecruitingHodgkin's Lymphoma | Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedAcute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Non-Hodgkins Lymphoma | Hodgkins LymphomaUnited States
-
Sun Yat-sen UniversityRecruitingRelapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)China
-
Kyowa Kirin Co., Ltd.Active, not recruitingRelapsed or Refractory Indolent B-cell Non-Hodgkin's LymphomaJapan
-
Seagen Inc.Bristol-Myers SquibbCompletedHodgkin Disease | Peripheral T Cell LymphomaUnited States, Canada
-
John ReneauRecruitingRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Adult T-Cell Leukemia/LymphomaUnited States
-
Aibin Liang,MD,Ph.D.RecruitingRefractory or Relapsed B-cell Non-Hodgkin LymphomaChina
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B-cells Non-Hodgkin LymphomaItaly
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
Icahn School of Medicine at Mount SinaiUnknownMultiple Myeloma | Hodgkin's Disease | Chronic Lymphocytic Lymphoma | Relapsed Non-Hodgkin's LymphomaUnited States
-
Genentech, Inc.Completed
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.; Hôpitaux Universitaires Henri Mondor, FranceCompletedHodgkin's LymphomaUnited States
-
ItalfarmacoCompleted
-
Syndax PharmaceuticalsTerminatedHodgkin's LymphomaUnited States
-
TG Therapeutics, Inc.CompletedHodgkin's LymphomaUnited States
-
Novartis PharmaceuticalsCompletedHodgkin's LymphomaUnited States, Belgium, Germany, Canada, Singapore, Netherlands, France, Australia, Russian Federation, Israel, Brazil, Italy, New Zealand, Poland
-
Ospedale Santa Croce-Carle CuneoFondazione Italiana Linfomi ONLUS; Consorzio Mario Negri SudUnknownHodgkin's LymphomaItaly